EP 1851320 A1 20071107 - VACCINES BASED ON THE USE OF MVA
Title (en)
VACCINES BASED ON THE USE OF MVA
Title (de)
AUF DER VERWENDUNG VON MVA BERUHENDE IMPFSTOFFE
Title (fr)
VACCINS À BASE DE L'UTILISATION DE MVA
Publication
Application
Priority
- EP 2006000608 W 20060124
- EP 05001362 A 20050124
- EP 06703897 A 20060124
Abstract (en)
[origin: EP1683870A1] The present invention is directed to a recombinant MVA, which carries a nucleic acid sequence coding for a fusion protein. The present invention is further directed to a kit of parts containing said recombinant MVA as well as to a method for enhancing T cell responses in a mammal.
IPC 8 full level
C12N 15/863 (2006.01); A61K 39/00 (2006.01); A61K 39/39 (2006.01)
CPC (source: EP US)
A61K 39/39 (2013.01 - EP US); A61P 31/04 (2018.01 - EP); A61P 31/12 (2018.01 - EP); A61P 33/00 (2018.01 - EP); A61P 35/00 (2018.01 - EP); A61P 37/04 (2018.01 - EP); A61P 43/00 (2018.01 - EP); C12N 15/86 (2013.01 - EP US); A61K 39/00 (2013.01 - EP US); A61K 2039/5256 (2013.01 - EP US); C12N 2710/24143 (2013.01 - EP US); Y02A 50/30 (2018.01 - EP US)
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
EP 1683870 A1 20060726; AT E539163 T1 20120115; CA 2595629 A1 20060727; CN 101142319 A 20080312; CN 101142319 B 20120523; DK 1851320 T3 20120416; EP 1851320 A1 20071107; EP 1851320 B1 20111228; ES 2380731 T3 20120517; JP 2008528457 A 20080731; JP 2013014588 A 20130124; US 2008075694 A1 20080327; WO 2006077161 A1 20060727
DOCDB simple family (application)
EP 05001362 A 20050124; AT 06703897 T 20060124; CA 2595629 A 20060124; CN 200680008160 A 20060124; DK 06703897 T 20060124; EP 06703897 A 20060124; EP 2006000608 W 20060124; ES 06703897 T 20060124; JP 2007551633 A 20060124; JP 2012158882 A 20120717; US 88001807 A 20070719